Oruka Therapeutics (ORKA) Share-based Compensation Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.65% |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | 224.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 224.46% |
| Dec 31, 2025 | 224.88% |
| Sep 30, 2025 | 371.46% |
| Jun 30, 2025 | 209.05% |
| Mar 31, 2025 | 208.08% |
| Dec 31, 2024 | 251.09% |
| Sep 30, 2024 | 342.34% |
| Jun 30, 2024 | 72.53% |
| Mar 31, 2024 | -10.82% |
| Dec 31, 2023 | 98.60% |
| Sep 30, 2023 | 213.46% |
| Jun 30, 2023 | 260.24% |
| Mar 31, 2023 | 133.62% |
| Dec 31, 2022 | 64.41% |
| Sep 30, 2022 | 49.55% |
| Jun 30, 2022 | 56.35% |
| Mar 31, 2022 | 49.48% |
| Dec 31, 2021 | 27.07% |
| Sep 30, 2021 | 21.49% |
| Jun 30, 2021 | 30.39% |
| Mar 31, 2021 | 13.28% |
| Dec 31, 2020 | -46.72% |
| Sep 30, 2020 | -65.24% |
| Jun 30, 2020 | -67.73% |
| Mar 31, 2020 | -45.89% |
| Dec 31, 2019 | 43.11% |
| Sep 30, 2019 | -52.29% |
| Jun 30, 2019 | -37.35% |
| Mar 31, 2019 | -31.42% |
| Dec 31, 2018 | -26.32% |
| Sep 30, 2018 | -26.98% |
| Jun 30, 2018 | -30.01% |
| Mar 31, 2018 | -9.30% |
| Dec 31, 2017 | -8.63% |
| Sep 30, 2017 | -9.59% |
| Jun 30, 2017 | -11.56% |
| Mar 31, 2017 | -13.86% |
| Dec 31, 2016 | -29.73% |
| Sep 30, 2016 | 75.97% |
| Jun 30, 2016 | 75.25% |
| Mar 31, 2016 | 54.54% |
| Dec 31, 2015 | 32.03% |
| Sep 30, 2015 | 26.28% |
| Jun 30, 2015 | 30.91% |
| Mar 31, 2015 | 12.62% |
| Dec 31, 2014 | 27.09% |
| Sep 30, 2014 | 26.78% |
| Jun 30, 2014 | 31.87% |
| Mar 31, 2014 | 26.53% |
| Dec 31, 2013 | 9.30% |
| Sep 30, 2013 | -24.31% |